N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome

Objective: To evaluate the effect of N-acetyl-cysteine (NAC) on insulin secretion and peripheral insulin resistance in subjects with polycystic ovary syndrome (PCOS). Design: Prospective data analysis. Setting: Volunteer women in an academic research environment. Patient(s): Six lean and 31 obese su...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fertility and sterility 2002-06, Vol.77 (6), p.1128-1135
Hauptverfasser: Fulghesu, Anna Maria, Ciampelli, Mario, Muzj, Giuseppe, Belosi, Chiara, Selvaggi, Luigi, Ayala, Gian Franco, Lanzone, Antonio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1135
container_issue 6
container_start_page 1128
container_title Fertility and sterility
container_volume 77
creator Fulghesu, Anna Maria
Ciampelli, Mario
Muzj, Giuseppe
Belosi, Chiara
Selvaggi, Luigi
Ayala, Gian Franco
Lanzone, Antonio
description Objective: To evaluate the effect of N-acetyl-cysteine (NAC) on insulin secretion and peripheral insulin resistance in subjects with polycystic ovary syndrome (PCOS). Design: Prospective data analysis. Setting: Volunteer women in an academic research environment. Patient(s): Six lean and 31 obese subjects, aged 19–33 years. Intervention(s): Patients were treated for 5–6 weeks with NAC at a dose of 1.8 g/day orally. A dose of 3 g/day was arbitrarily chosen for massively obese subjects. Six of 31 obese patients with PCOS were treated with placebo and served as controls. Main Outcome Measure(s): Before and after the treatment period, the hormonal and lipid blood profile and insulin sensitivity, assessed by an hyperinsulinemic euglycemic clamp, were evaluated and an oral glucose tolerance test (OGTT) was performed. Result(s): Fasting glucose, fasting insulin, and glucose area under curve (AUC) were unchanged after treatment. Insulin AUC after OGTT was significantly reduced, and the peripheral insulin sensitivity increased after NAC administration, whereas the hepatic insulin extraction was unaffected. The NAC treatment induced a significant fall in T levels and in free androgen index values ( P
doi_str_mv 10.1016/S0015-0282(02)03133-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71820854</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0015028202031333</els_id><sourcerecordid>71820854</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-4a2f8431d246b1c4fcbf0df4f6f1f7ef3f1541918eb135e78151d7537405f28b3</originalsourceid><addsrcrecordid>eNqFkE1v1DAQhi0EotvCT6DyBdQeAh5_xOkJoYq2SBUcgLNxnLFwlThb27tV_j3e7qo9chlL42dmXj2EvAP2ERi0n34yBqphvONnjJ8zAUI04gVZgVJto1olXpLVE3JEjnO-Y4y1oPlrcgScKa1Br8if7411WJaxcUsuGCLSktCWCWOhYVqneYuZhpg3Y4g0Y8yhhG0oS-3Rh7li9CGUv3Q9j8tuQ3B03tq00LzEIdX_N-SVt2PGt4f3hPy--vrr8qa5_XH97fLLbeOk6EojLfedFDBw2fbgpHe9Z4OXvvXgNXrhQUm4gA57EAp1BwoGrYSWTHne9eKEfNjvrZHvN5iLmUJ2OI424rzJRkPHWadkBdUedGnOOaE36xSmGtkAMzu15lGt2XmrxTyqNaLOnR4ObPoJh-epg8sKvD8ANjs7-mSjC_mZE1pcMA2V-7znsOrYBkwmu4DR4RASumKGOfwnyj8vbJc0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71820854</pqid></control><display><type>article</type><title>N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Fulghesu, Anna Maria ; Ciampelli, Mario ; Muzj, Giuseppe ; Belosi, Chiara ; Selvaggi, Luigi ; Ayala, Gian Franco ; Lanzone, Antonio</creator><creatorcontrib>Fulghesu, Anna Maria ; Ciampelli, Mario ; Muzj, Giuseppe ; Belosi, Chiara ; Selvaggi, Luigi ; Ayala, Gian Franco ; Lanzone, Antonio</creatorcontrib><description>Objective: To evaluate the effect of N-acetyl-cysteine (NAC) on insulin secretion and peripheral insulin resistance in subjects with polycystic ovary syndrome (PCOS). Design: Prospective data analysis. Setting: Volunteer women in an academic research environment. Patient(s): Six lean and 31 obese subjects, aged 19–33 years. Intervention(s): Patients were treated for 5–6 weeks with NAC at a dose of 1.8 g/day orally. A dose of 3 g/day was arbitrarily chosen for massively obese subjects. Six of 31 obese patients with PCOS were treated with placebo and served as controls. Main Outcome Measure(s): Before and after the treatment period, the hormonal and lipid blood profile and insulin sensitivity, assessed by an hyperinsulinemic euglycemic clamp, were evaluated and an oral glucose tolerance test (OGTT) was performed. Result(s): Fasting glucose, fasting insulin, and glucose area under curve (AUC) were unchanged after treatment. Insulin AUC after OGTT was significantly reduced, and the peripheral insulin sensitivity increased after NAC administration, whereas the hepatic insulin extraction was unaffected. The NAC treatment induced a significant fall in T levels and in free androgen index values ( P&lt;.05). In analyzing patients according to their insulinemic response to OGTT, normoinsulinemic subjects and placebo-treated patients did not show any modification of the above parameters, whereas a significant improvement was observed in hyperinsulinemic subjects. Conclusion(s): NAC may be a new treatment for the improvement of insulin circulating levels and insulin sensitivity in hyperinsulinemic patients with polycystic ovary syndrome.</description><identifier>ISSN: 0015-0282</identifier><identifier>EISSN: 1556-5653</identifier><identifier>DOI: 10.1016/S0015-0282(02)03133-3</identifier><identifier>PMID: 12057717</identifier><identifier>CODEN: FESTAS</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acetylcysteine - administration &amp; dosage ; Acetylcysteine - therapeutic use ; Adult ; Androgens - blood ; Biological and medical sciences ; Drug Administration Schedule ; Female ; Female genital diseases ; Glucose Tolerance Test ; Gynecology. Andrology. Obstetrics ; Humans ; Hyperinsulinism - blood ; insulin ; Insulin - blood ; Insulin - metabolism ; insulin resistance ; Insulin Resistance - physiology ; Liver - metabolism ; Medical sciences ; N-acetyl-cysteine ; obesity ; Polycystic ovary syndrome ; Polycystic Ovary Syndrome - drug therapy ; Polycystic Ovary Syndrome - physiopathology ; Prospective Studies ; Testosterone - blood ; Tumors</subject><ispartof>Fertility and sterility, 2002-06, Vol.77 (6), p.1128-1135</ispartof><rights>2002 American Society for Reproductive Medicine</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-4a2f8431d246b1c4fcbf0df4f6f1f7ef3f1541918eb135e78151d7537405f28b3</citedby><cites>FETCH-LOGICAL-c438t-4a2f8431d246b1c4fcbf0df4f6f1f7ef3f1541918eb135e78151d7537405f28b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0015028202031333$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13739071$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12057717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fulghesu, Anna Maria</creatorcontrib><creatorcontrib>Ciampelli, Mario</creatorcontrib><creatorcontrib>Muzj, Giuseppe</creatorcontrib><creatorcontrib>Belosi, Chiara</creatorcontrib><creatorcontrib>Selvaggi, Luigi</creatorcontrib><creatorcontrib>Ayala, Gian Franco</creatorcontrib><creatorcontrib>Lanzone, Antonio</creatorcontrib><title>N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome</title><title>Fertility and sterility</title><addtitle>Fertil Steril</addtitle><description>Objective: To evaluate the effect of N-acetyl-cysteine (NAC) on insulin secretion and peripheral insulin resistance in subjects with polycystic ovary syndrome (PCOS). Design: Prospective data analysis. Setting: Volunteer women in an academic research environment. Patient(s): Six lean and 31 obese subjects, aged 19–33 years. Intervention(s): Patients were treated for 5–6 weeks with NAC at a dose of 1.8 g/day orally. A dose of 3 g/day was arbitrarily chosen for massively obese subjects. Six of 31 obese patients with PCOS were treated with placebo and served as controls. Main Outcome Measure(s): Before and after the treatment period, the hormonal and lipid blood profile and insulin sensitivity, assessed by an hyperinsulinemic euglycemic clamp, were evaluated and an oral glucose tolerance test (OGTT) was performed. Result(s): Fasting glucose, fasting insulin, and glucose area under curve (AUC) were unchanged after treatment. Insulin AUC after OGTT was significantly reduced, and the peripheral insulin sensitivity increased after NAC administration, whereas the hepatic insulin extraction was unaffected. The NAC treatment induced a significant fall in T levels and in free androgen index values ( P&lt;.05). In analyzing patients according to their insulinemic response to OGTT, normoinsulinemic subjects and placebo-treated patients did not show any modification of the above parameters, whereas a significant improvement was observed in hyperinsulinemic subjects. Conclusion(s): NAC may be a new treatment for the improvement of insulin circulating levels and insulin sensitivity in hyperinsulinemic patients with polycystic ovary syndrome.</description><subject>Acetylcysteine - administration &amp; dosage</subject><subject>Acetylcysteine - therapeutic use</subject><subject>Adult</subject><subject>Androgens - blood</subject><subject>Biological and medical sciences</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Glucose Tolerance Test</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Hyperinsulinism - blood</subject><subject>insulin</subject><subject>Insulin - blood</subject><subject>Insulin - metabolism</subject><subject>insulin resistance</subject><subject>Insulin Resistance - physiology</subject><subject>Liver - metabolism</subject><subject>Medical sciences</subject><subject>N-acetyl-cysteine</subject><subject>obesity</subject><subject>Polycystic ovary syndrome</subject><subject>Polycystic Ovary Syndrome - drug therapy</subject><subject>Polycystic Ovary Syndrome - physiopathology</subject><subject>Prospective Studies</subject><subject>Testosterone - blood</subject><subject>Tumors</subject><issn>0015-0282</issn><issn>1556-5653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1v1DAQhi0EotvCT6DyBdQeAh5_xOkJoYq2SBUcgLNxnLFwlThb27tV_j3e7qo9chlL42dmXj2EvAP2ERi0n34yBqphvONnjJ8zAUI04gVZgVJto1olXpLVE3JEjnO-Y4y1oPlrcgScKa1Br8if7411WJaxcUsuGCLSktCWCWOhYVqneYuZhpg3Y4g0Y8yhhG0oS-3Rh7li9CGUv3Q9j8tuQ3B03tq00LzEIdX_N-SVt2PGt4f3hPy--vrr8qa5_XH97fLLbeOk6EojLfedFDBw2fbgpHe9Z4OXvvXgNXrhQUm4gA57EAp1BwoGrYSWTHne9eKEfNjvrZHvN5iLmUJ2OI424rzJRkPHWadkBdUedGnOOaE36xSmGtkAMzu15lGt2XmrxTyqNaLOnR4ObPoJh-epg8sKvD8ANjs7-mSjC_mZE1pcMA2V-7znsOrYBkwmu4DR4RASumKGOfwnyj8vbJc0</recordid><startdate>20020601</startdate><enddate>20020601</enddate><creator>Fulghesu, Anna Maria</creator><creator>Ciampelli, Mario</creator><creator>Muzj, Giuseppe</creator><creator>Belosi, Chiara</creator><creator>Selvaggi, Luigi</creator><creator>Ayala, Gian Franco</creator><creator>Lanzone, Antonio</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020601</creationdate><title>N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome</title><author>Fulghesu, Anna Maria ; Ciampelli, Mario ; Muzj, Giuseppe ; Belosi, Chiara ; Selvaggi, Luigi ; Ayala, Gian Franco ; Lanzone, Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-4a2f8431d246b1c4fcbf0df4f6f1f7ef3f1541918eb135e78151d7537405f28b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Acetylcysteine - administration &amp; dosage</topic><topic>Acetylcysteine - therapeutic use</topic><topic>Adult</topic><topic>Androgens - blood</topic><topic>Biological and medical sciences</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Glucose Tolerance Test</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Hyperinsulinism - blood</topic><topic>insulin</topic><topic>Insulin - blood</topic><topic>Insulin - metabolism</topic><topic>insulin resistance</topic><topic>Insulin Resistance - physiology</topic><topic>Liver - metabolism</topic><topic>Medical sciences</topic><topic>N-acetyl-cysteine</topic><topic>obesity</topic><topic>Polycystic ovary syndrome</topic><topic>Polycystic Ovary Syndrome - drug therapy</topic><topic>Polycystic Ovary Syndrome - physiopathology</topic><topic>Prospective Studies</topic><topic>Testosterone - blood</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fulghesu, Anna Maria</creatorcontrib><creatorcontrib>Ciampelli, Mario</creatorcontrib><creatorcontrib>Muzj, Giuseppe</creatorcontrib><creatorcontrib>Belosi, Chiara</creatorcontrib><creatorcontrib>Selvaggi, Luigi</creatorcontrib><creatorcontrib>Ayala, Gian Franco</creatorcontrib><creatorcontrib>Lanzone, Antonio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Fertility and sterility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fulghesu, Anna Maria</au><au>Ciampelli, Mario</au><au>Muzj, Giuseppe</au><au>Belosi, Chiara</au><au>Selvaggi, Luigi</au><au>Ayala, Gian Franco</au><au>Lanzone, Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome</atitle><jtitle>Fertility and sterility</jtitle><addtitle>Fertil Steril</addtitle><date>2002-06-01</date><risdate>2002</risdate><volume>77</volume><issue>6</issue><spage>1128</spage><epage>1135</epage><pages>1128-1135</pages><issn>0015-0282</issn><eissn>1556-5653</eissn><coden>FESTAS</coden><abstract>Objective: To evaluate the effect of N-acetyl-cysteine (NAC) on insulin secretion and peripheral insulin resistance in subjects with polycystic ovary syndrome (PCOS). Design: Prospective data analysis. Setting: Volunteer women in an academic research environment. Patient(s): Six lean and 31 obese subjects, aged 19–33 years. Intervention(s): Patients were treated for 5–6 weeks with NAC at a dose of 1.8 g/day orally. A dose of 3 g/day was arbitrarily chosen for massively obese subjects. Six of 31 obese patients with PCOS were treated with placebo and served as controls. Main Outcome Measure(s): Before and after the treatment period, the hormonal and lipid blood profile and insulin sensitivity, assessed by an hyperinsulinemic euglycemic clamp, were evaluated and an oral glucose tolerance test (OGTT) was performed. Result(s): Fasting glucose, fasting insulin, and glucose area under curve (AUC) were unchanged after treatment. Insulin AUC after OGTT was significantly reduced, and the peripheral insulin sensitivity increased after NAC administration, whereas the hepatic insulin extraction was unaffected. The NAC treatment induced a significant fall in T levels and in free androgen index values ( P&lt;.05). In analyzing patients according to their insulinemic response to OGTT, normoinsulinemic subjects and placebo-treated patients did not show any modification of the above parameters, whereas a significant improvement was observed in hyperinsulinemic subjects. Conclusion(s): NAC may be a new treatment for the improvement of insulin circulating levels and insulin sensitivity in hyperinsulinemic patients with polycystic ovary syndrome.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>12057717</pmid><doi>10.1016/S0015-0282(02)03133-3</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0015-0282
ispartof Fertility and sterility, 2002-06, Vol.77 (6), p.1128-1135
issn 0015-0282
1556-5653
language eng
recordid cdi_proquest_miscellaneous_71820854
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Acetylcysteine - administration & dosage
Acetylcysteine - therapeutic use
Adult
Androgens - blood
Biological and medical sciences
Drug Administration Schedule
Female
Female genital diseases
Glucose Tolerance Test
Gynecology. Andrology. Obstetrics
Humans
Hyperinsulinism - blood
insulin
Insulin - blood
Insulin - metabolism
insulin resistance
Insulin Resistance - physiology
Liver - metabolism
Medical sciences
N-acetyl-cysteine
obesity
Polycystic ovary syndrome
Polycystic Ovary Syndrome - drug therapy
Polycystic Ovary Syndrome - physiopathology
Prospective Studies
Testosterone - blood
Tumors
title N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T04%3A16%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N-acetyl-cysteine%20treatment%20improves%20insulin%20sensitivity%20in%20women%20with%20polycystic%20ovary%20syndrome&rft.jtitle=Fertility%20and%20sterility&rft.au=Fulghesu,%20Anna%20Maria&rft.date=2002-06-01&rft.volume=77&rft.issue=6&rft.spage=1128&rft.epage=1135&rft.pages=1128-1135&rft.issn=0015-0282&rft.eissn=1556-5653&rft.coden=FESTAS&rft_id=info:doi/10.1016/S0015-0282(02)03133-3&rft_dat=%3Cproquest_cross%3E71820854%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71820854&rft_id=info:pmid/12057717&rft_els_id=S0015028202031333&rfr_iscdi=true